Our injectable portfolio includes small molecules, peptides & recombinant proteins. These products would be manufactured in our 'Fill & Finish' sterile plant.
- Eptifibatide Injection 20mg/10 ml & 75mg/100 ml (Anti-Thrombotic Agent)
- Bivalirudin Injection 250 mg lyophilized powder in 10ml vial (Anti-Thrombotic Agent)
- Dolasetron Mesylate Injection 20mg/ml (5ml in 10ml vial & 0.625ml in 2 ml vial) (Anti Emetic, 5-HT inhibitor)
- Octreotide Injection 50, 100, 500 mcg/ml single dose (1 ml in 2 ml vial) and 200, 1000 mcg/ml multidose vial (5 ml in 5 ml vial) (Somatostatin, Growth Hormone Inhibitor)
- Zoledronic Acid Injection 4mg/5 ml liquid concentrate (Bisphosphonate, for the prevention of fractures in Cancer patients
- Somatropin For Injection 5mg Lyophilised powder (Human Growth Hormone)
- Teriparatide Injection 750 mcg in 3 ml (Parathyroid Hormone)
- Granulocyte - Colony Stimulating Factor (Filgrastim) Injection 300mcg/ml & 480mcg/1.6 ml (Treatment of Chemoptherapy induced Neutropenia)
For more information about our existing portfolio and our pipeline products please e-mail us.
Disclaimer: Products under patents are offered for sale only in those countries where patents have expired.